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• They consist of three parts: self-immolative spacers, trigger moieties,
and a substrate such as drug5
• Upon stimulus, cleavage of the trigger moiety occurs along with a
cascade of disassembly reactions which result in the release of the
substrate6
Figure 2. Overview of a self-immolative prodrug process
Scheme 1. Mechanism of self-immolative prodrug
Figure 3. 1H NMR spectrum from attempted radical 
bromination, showing disappearance of TBS protecting group, 
suggesting hydrolysis
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Theranostic agents, a class of molecules that simultaneously serve both
a diagnostic and therapeutic function, enable in vivo imaging for early
diagnosis and targeted drug delivery within a single entity. Due to recent
advances in the synthesis and photophysical properties of the rhodamine
scaffold, rhodamine dyes present a promising new direction for
theranostic research. Toward the goal of exploring rhodamine dyes as
self-immolative prodrugs for theranostic applications, we have
synthesized a rhodamine precursor via a telescoped radical
bromination/hydrolysis. Upon completion of the full rhodamine synthesis,
we will explore and optimize the kinetics of its “turn-on” fluorescence and
drug release in vitro.
Conclusions
Synthesis of Self-Immolative Rhodamine Based Theranostic Agent
• Many cancers go undetected until late-stage, when prognosis is
poor1; thus early detection is vital to improving patient outcomes2
• Theranostic enables simultaneous in vivo
imaging for early diagnosis and
targeted drug delivery within a
single entity3
• Single-molecular theranostic
agents (SMTA) offer the
benefit of synthetic modularity,
higher membrane permeability,
easier renal clearance,
and a cheaper cost of production4
Rhodamine
• Test the kinetics of the self-immolative drug release mechanism by
attaching a fluorinated reporter to the labile thiocarbonate and a
disulfide-based trigger to the aniline.
• Monitor the progress of the self-immolation reaction via the release of
the fluorinated motif using 19F-NMR
• Based on the data collected from these tests, the optimal isomer will
be further modified to improve the time it takes for the drug to be
released
Completion of the Rhodamine Synthesis
Derivatization of Commercially Available Rhodamines
Testing Kinetics of Self-Immolative Process
• The goal of this research is to explore rhodamine dyes as self-
immolative prodrugs for theranostic applications
• We aim to develop an efficient synthesis of polysubstituted
rhodamines and optimize the kinetics of “turn-on” fluorescence and
drug release in vitro
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Rhodamine 6G
• We have synthesized a para-rhodamine precursor in 2 steps and 
22.5% overall yield 
• Developed a telescoped radical bromination and hydrolysis that 
creates a more efficient synthesis of the rhodamine scaffold that 
eliminates an extra workup and purification step
Scheme 4: Failed radical bromination due to hydrolysis
Figure 1. Cancer theranostic enables 
both diagnostic imaging and drug 
delivery7
Scheme 2. Example application and mechanism of self-immolative
rhodamine based theranostic agent
Scheme 5. Telescoped radical bromination and hydrolysis 
Figure 5. TLC and mass spectra from telescoped NBS radical bromination and 
Hydrolysis
Figure 4. 1H NMR spectra from telescoped NBS radical bromination and 
hydrolysis
Scheme 6. Synthesis of para-functionalized Rhodamine
Scheme 7. Proposed mechanism of rhodamine formation
Scheme 8. Functionalization of Rhodamine 6G 
• Originally, we attempted to obtain phenol 4 via a radical bromination to yield bromide 7. This 
would be followed by hydrolysis with dioxane/water. 
• TLC and 1H NMR from the attempted NBS bromination suggested the product quickly 
underwent hydrolysis to form a mixture of products, including the originally desired alcohol 4
as the major product (figure 3)
• This inspired us to experiment with a telescoped bromination and hydrolysis (scheme 5)
Bromination
+
Hydrolysis
• Telescoping is a technique in organic synthesis in which a reactant is 
subjected to successive chemical reactions in one flask.  
• By telescoping the NBS bromination and hydrolysis, an intermediate workup 
and purification step is avoided (scheme 5)
• The product of the telescoped reaction was confirmed via 1H NMR (figure 4) 
and mass spectrometry (figure 5)
Results and Discussion
Telescoped NBS Bromination and Hydrolysis
Failed NBS Radical Bromination
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Scheme 3: Retrosynthesis of Para Functionalized Rhodamine
